With aging populations and lifestyle factors like smoking exacerbating ... Immunotherapy: The fastest-growing segment, immunotherapies like PD-1 and PD-L1 inhibitors (e.g., Keytruda) are expected to ...

such as variations in programmed cell death protein ligand 1 (PD-L1) expression. The National Cancer Database, however, lacked specific data about whether patients were tested for sensitivity to ...

1. Fusion2 Given the inherent differences between genetic and MRI modalities in characterizing Parkinson’s disease (PD), feature variable groups exist within the multimodal feature matrix. Traditional ...

The anti-aging and anti-inflammatory properties of krill oil may help ... Krill oil extract inhibits the migration of human colorectal cancer cells and down-regulates EGFR signalling and PD-L1 ...

Technologies announced its PD-L1 IHC 28-8 pharmDx kit has received two new companion diagnostic indications approvals under EU ...

Sun Pharma’s acquisition of Checkpoint Therapeutics includes Unloxcyt, an FDA-approved anti-PD-L1 therapy for metastatic and ...

A new study published in AI in Precision Oncology examines the ability of large language models (LLMs) to rapidly extract ...

Tislelizumab plus chemotherapy received FDA approval as a frontline therapy for individuals with unresectable or metastatic ...

By contrast, preclinical studies have suggested that a combination of ICIs that target different immune checkpoints -- durvalumab, which targets PD-L1, and tremelimumab, which targets CTLA-4 ...